Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00067938
Other study ID # SCA40917
Secondary ID
Status Completed
Phase Phase 4
First received September 3, 2003
Last updated August 31, 2016
Start date August 2003
Est. completion date August 2004

Study information

Verified date August 2016
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Bipolar study of tolerability, clinical response and patient satisfaction


Recruitment information / eligibility

Status Completed
Enrollment 1200
Est. completion date August 2004
Est. primary completion date August 2004
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of bipolar I disorder.

- Must be on a stable regimen of psychiatric medication for at least 2 months prior to study.

- If female, must not be pregnant, or must be incapable of conceiving or be taking steps to prevent conception.

Exclusion Criteria:

- Patients with a clinically significant psychiatric or physiologic comorbidity including significant substance abuse, depression or mania which is of an unstable of progressive nature that could interfere in participation of this study.

- Presence of untreated thyroid disease.

- Patient is actively suicidal or homicidal.

- Patient has history of severe hepatic or renal insufficiency.

- Patient is currently participating in another clinical trial.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
lamotrigine
Lamotrigine

Locations

Country Name City State
United States GSK Investigational Site Adrian Michigan
United States GSK Investigational Site Albany New York
United States GSK Investigational Site Albertville Alabama
United States GSK Investigational Site Albuquerque New Mexico
United States GSK Investigational Site Altamonte Springs Florida
United States GSK Investigational Site Alton Illinois
United States GSK Investigational Site Amityville New York
United States GSK Investigational Site Annapolis Maryland
United States GSK Investigational Site Anniston Alabama
United States GSK Investigational Site Arlington Texas
United States GSK Investigational Site Arlington Virginia
United States GSK Investigational Site Ashburn Virginia
United States GSK Investigational Site Atlanta Georgia
United States GSK Investigational Site Atlanta Georgia
United States GSK Investigational Site Atlanta Georgia
United States GSK Investigational Site Austin Texas
United States GSK Investigational Site Avon Lake Ohio
United States GSK Investigational Site Bakersfield California
United States GSK Investigational Site Baltimore Maryland
United States GSK Investigational Site Batlimore Maryland
United States GSK Investigational Site Baton Rouge Louisiana
United States GSK Investigational Site Bay City Michigan
United States GSK Investigational Site Bedford Texas
United States GSK Investigational Site Bellingham Washington
United States GSK Investigational Site Benton Harbor Michigan
United States GSK Investigational Site Beverly Hills California
United States GSK Investigational Site Billings Montana
United States GSK Investigational Site Birmingham Alabama
United States GSK Investigational Site Birmingham Alabama
United States GSK Investigational Site Birmingham Alabama
United States GSK Investigational Site Bloomfield Hills Michigan
United States GSK Investigational Site Boca Raton Florida
United States GSK Investigational Site Boca Raton Florida
United States GSK Investigational Site Boise Idaho
United States GSK Investigational Site Boise Idaho
United States GSK Investigational Site Boise Idaho
United States GSK Investigational Site Boulder Colorado
United States GSK Investigational Site Bourbonnais Illinois
United States GSK Investigational Site Boynton Beach Florida
United States GSK Investigational Site Bradenton Florida
United States GSK Investigational Site Brandon Florida
United States GSK Investigational Site Bristol Tennessee
United States GSK Investigational Site Bronx New York
United States GSK Investigational Site Brownstown Township Michigan
United States GSK Investigational Site Burbank California
United States GSK Investigational Site Burtonsville Maryland
United States GSK Investigational Site Campbell California
United States GSK Investigational Site Cary North Carolina
United States GSK Investigational Site Casselberry Florida
United States GSK Investigational Site Cedar Rapids Iowa
United States GSK Investigational Site Cerritos California
United States GSK Investigational Site Chandler Arizona
United States GSK Investigational Site Chapel Hill North Carolina
United States GSK Investigational Site Chapel Hill North Carolina
United States GSK Investigational Site Charleston South Carolina
United States GSK Investigational Site Charleston West Virginia
United States GSK Investigational Site Charleston West Virginia
United States GSK Investigational Site Charlotte North Carolina
United States GSK Investigational Site Charlottesville Virginia
United States GSK Investigational Site Charlottesville Virginia
United States GSK Investigational Site Chicago Illinois
United States GSK Investigational Site Christiansburg Virginia
United States GSK Investigational Site Cincinnati Ohio
United States GSK Investigational Site Cincinnati Ohio
United States GSK Investigational Site Clearwater Florida
United States GSK Investigational Site Clinton Township Michigan
United States GSK Investigational Site Colmar Pennsylvania
United States GSK Investigational Site Conroe Texas
United States GSK Investigational Site Coral Springs Florida
United States GSK Investigational Site Cordova Tennessee
United States GSK Investigational Site Cornelius North Carolina
United States GSK Investigational Site Cuyahoga Falls Ohio
United States GSK Investigational Site Dallas Texas
United States GSK Investigational Site Danville Virginia
United States GSK Investigational Site Danville Indiana
United States GSK Investigational Site Davie Florida
United States GSK Investigational Site Dayton Ohio
United States GSK Investigational Site Daytona Beach Florida
United States GSK Investigational Site Decatur Georgia
United States GSK Investigational Site Destin Florida
United States GSK Investigational Site Doyletown Pennsylvania
United States GSK Investigational Site Dubuque Iowa
United States GSK Investigational Site Duluth Minnesota
United States GSK Investigational Site Durham North Carolina
United States GSK Investigational Site East Lansing Michigan
United States GSK Investigational Site East Moline Illinois
United States GSK Investigational Site El Centro California
United States GSK Investigational Site Ellicott City Maryland
United States GSK Investigational Site Evansville Indiana
United States GSK Investigational Site Everett Washington
United States GSK Investigational Site Evergreen Park Illinois
United States GSK Investigational Site Fairfield California
United States GSK Investigational Site Fairhope Alabama
United States GSK Investigational Site Fairview Heights Illinois
United States GSK Investigational Site Falls Church Virginia
United States GSK Investigational Site Farmingdale New York
United States GSK Investigational Site Farmington Hills Michigan
United States GSK Investigational Site Fayetteville North Carolina
United States GSK Investigational Site Flint Michigan
United States GSK Investigational Site Flint Michigan
United States GSK Investigational Site Flowood Mississippi
United States GSK Investigational Site Forest City North Carolina
United States GSK Investigational Site Fort Collins Colorado
United States GSK Investigational Site Fort Smith Arkansas
United States GSK Investigational Site Fort Walton Beach Florida
United States GSK Investigational Site Fort Wayne Indiana
United States GSK Investigational Site Gainesville Florida
United States GSK Investigational Site Gaithersburg Maryland
United States GSK Investigational Site Glen Burnie Maryland
United States GSK Investigational Site Goldsboro North Carolina
United States GSK Investigational Site Granite City Illinois
United States GSK Investigational Site Greensboro North Carolina
United States GSK Investigational Site Greenville North Carolina
United States GSK Investigational Site Greenville North Carolina
United States GSK Investigational Site Gulfport Mississippi
United States GSK Investigational Site Hamden Connecticut
United States GSK Investigational Site Henderson Nevada
United States GSK Investigational Site High Point North Carolina
United States GSK Investigational Site Hopkinsville Kentucky
United States GSK Investigational Site Houma Louisiana
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Houston Texas
United States GSK Investigational Site Humble Texas
United States GSK Investigational Site Humble Texas
United States GSK Investigational Site Huntsville Alabama
United States GSK Investigational Site Irving Texas
United States GSK Investigational Site Jacksonville Florida
United States GSK Investigational Site Jacksonville Florida
United States GSK Investigational Site Jacksonville Beach Florida
United States GSK Investigational Site Johnson City Tennessee
United States GSK Investigational Site Joliet Illinois
United States GSK Investigational Site Joplin Missouri
United States GSK Investigational Site Kansas City Missouri
United States GSK Investigational Site Kingsport Tennessee
United States GSK Investigational Site Kingston Pennsylvania
United States GSK Investigational Site Kingwood Texas
United States GSK Investigational Site Knoxville Tennessee
United States GSK Investigational Site Knoxville Tennessee
United States GSK Investigational Site La Mesa California
United States GSK Investigational Site Lafayette Indiana
United States GSK Investigational Site Laguna Hills California
United States GSK Investigational Site Lake Charles Louisiana
United States GSK Investigational Site Lakeland Florida
United States GSK Investigational Site Las Cruces New Mexico
United States GSK Investigational Site Las Vegas Nevada
United States GSK Investigational Site Las Vegas Nevada
United States GSK Investigational Site Latham New York
United States GSK Investigational Site Laurel Maryland
United States GSK Investigational Site Lawrenceville Georgia
United States GSK Investigational Site Leavenworth Kansas
United States GSK Investigational Site Lexington Kentucky
United States GSK Investigational Site Libertyville Illinois
United States GSK Investigational Site Lincoln Nebraska
United States GSK Investigational Site Lisle Illinois
United States GSK Investigational Site Little Rock Arkansas
United States GSK Investigational Site Long Branch New Jersey
United States GSK Investigational Site Los Angeles California
United States GSK Investigational Site Los Angeles California
United States GSK Investigational Site Macon Georgia
United States GSK Investigational Site Madison Tennessee
United States GSK Investigational Site Manchester New Hampshire
United States GSK Investigational Site Mansfield Center Connecticut
United States GSK Investigational Site McKeesport Pennsylvania
United States GSK Investigational Site Media Pennsylvania
United States GSK Investigational Site Mequion Wisconsin
United States GSK Investigational Site Miami Florida
United States GSK Investigational Site Miami Florida
United States GSK Investigational Site Miami Florida
United States GSK Investigational Site Miami Florida
United States GSK Investigational Site Midlothian Virginia
United States GSK Investigational Site Milwaukee Wisconsin
United States GSK Investigational Site Milwaukie Oregon
United States GSK Investigational Site Minneapolis Minnesota
United States GSK Investigational Site Mishawaka Indiana
United States GSK Investigational Site Moncks Corner South Carolina
United States GSK Investigational Site Mount Clemens Michigan
United States GSK Investigational Site Murfreesboro Tennessee
United States GSK Investigational Site Nacogdoches Texas
United States GSK Investigational Site Nashville Tennessee
United States GSK Investigational Site Nashville Tennessee
United States GSK Investigational Site Natrona Heights Pennsylvania
United States GSK Investigational Site New Rochelle New York
United States GSK Investigational Site New York New York
United States GSK Investigational Site Newark Delaware
United States GSK Investigational Site Newport News Virginia
United States GSK Investigational Site Norfolk Virginia
United States GSK Investigational Site North Charleston South Carolina
United States GSK Investigational Site North Little Rock Arkansas
United States GSK Investigational Site North Miami Florida
United States GSK Investigational Site Norwich Connecticut
United States GSK Investigational Site Oakbrook Terrace Illinois
United States GSK Investigational Site Oakdale Minnesota
United States GSK Investigational Site Ocala Florida
United States GSK Investigational Site Ocala Florida
United States GSK Investigational Site Oceanside California
United States GSK Investigational Site Oklahoma City Oklahoma
United States GSK Investigational Site Oklahoma City Oklahoma
United States GSK Investigational Site Oklahoma City Oklahoma
United States GSK Investigational Site Oklahoma City Oklahoma
United States GSK Investigational Site Olean New York
United States GSK Investigational Site Omaha Nebraska
United States GSK Investigational Site Omaha Nebraska
United States GSK Investigational Site Orange City Florida
United States GSK Investigational Site Orland Park Illinois
United States GSK Investigational Site Orlando Florida
United States GSK Investigational Site Overland Park Kansas
United States GSK Investigational Site Palm Beach Gardens Florida
United States GSK Investigational Site Park Ridge Illinois
United States GSK Investigational Site Pensacola Florida
United States GSK Investigational Site Petaluma California
United States GSK Investigational Site Philadelphia Pennsylvania
United States GSK Investigational Site Phoenix Arizona
United States GSK Investigational Site Phoenix Arizona
United States GSK Investigational Site Phoenix Arizona
United States GSK Investigational Site Phoenix Arizona
United States GSK Investigational Site Pittsburgh Pennsylvania
United States GSK Investigational Site Plantation Florida
United States GSK Investigational Site Plymouth Indiana
United States GSK Investigational Site Port Jefferson New York
United States GSK Investigational Site Portland Oregon
United States GSK Investigational Site Portsmouth Virginia
United States GSK Investigational Site Poway California
United States GSK Investigational Site Princeton New Jersey
United States GSK Investigational Site Racine Wisconsin
United States GSK Investigational Site Raleigh North Carolina
United States GSK Investigational Site Raleigh North Carolina
United States GSK Investigational Site Raleigh North Carolina
United States GSK Investigational Site Raleigh North Carolina
United States GSK Investigational Site Reading Pennsylvania
United States GSK Investigational Site Renton Washington
United States GSK Investigational Site Richmond Virginia
United States GSK Investigational Site Riverside California
United States GSK Investigational Site Rochester Hills Michigan
United States GSK Investigational Site Rockford Illinois
United States GSK Investigational Site Rockville Maryland
United States GSK Investigational Site Rogers Arizona
United States GSK Investigational Site Roswell Georgia
United States GSK Investigational Site Royal Oak Michigan
United States GSK Investigational Site Sacramento California
United States GSK Investigational Site Salt Lake City Utah
United States GSK Investigational Site San Antonio Texas
United States GSK Investigational Site San Antonio Texas
United States GSK Investigational Site San Diego California
United States GSK Investigational Site San Diego California
United States GSK Investigational Site San Diego California
United States GSK Investigational Site San Jose California
United States GSK Investigational Site Santa Ana California
United States GSK Investigational Site Santa Barbara California
United States GSK Investigational Site Sarasota Florida
United States GSK Investigational Site Schaumburg Illinois
United States GSK Investigational Site Shawnee Mission Kansas
United States GSK Investigational Site Sherman Oaks California
United States GSK Investigational Site Shreveport Louisiana
United States GSK Investigational Site Smithtown New York
United States GSK Investigational Site Spokane Washington
United States GSK Investigational Site Springfield Missouri
United States GSK Investigational Site St. Charles Missouri
United States GSK Investigational Site St. Louis Missouri
United States GSK Investigational Site St. Louis Missouri
United States GSK Investigational Site St. Louis Missouri
United States GSK Investigational Site St. Petersburg Florida
United States GSK Investigational Site St. Petersburg Florida
United States GSK Investigational Site Stockbridge Georgia
United States GSK Investigational Site Suffolk Virginia
United States GSK Investigational Site Sugar Land Texas
United States GSK Investigational Site Syracuse Florida
United States GSK Investigational Site Tacoma Washington
United States GSK Investigational Site Tampa Florida
United States GSK Investigational Site Topeka Kansas
United States GSK Investigational Site Torrance California
United States GSK Investigational Site Towson Maryland
United States GSK Investigational Site Towson Maryland
United States GSK Investigational Site Tucson Arizona
United States GSK Investigational Site Tulsa Oklahoma
United States GSK Investigational Site Tulsa Oklahoma
United States GSK Investigational Site Tuscaloosa Alabama
United States GSK Investigational Site Tyler Texas
United States GSK Investigational Site Valparaiso Indiana
United States GSK Investigational Site Vernon Hills Illinois
United States GSK Investigational Site Virginia Beach Virginia
United States GSK Investigational Site Warner Robins Georgia
United States GSK Investigational Site Warren Ohio
United States GSK Investigational Site Washington District of Columbia
United States GSK Investigational Site Waukesha Wisconsin
United States GSK Investigational Site Wauwatosa Wisconsin
United States GSK Investigational Site Weirton West Virginia
United States GSK Investigational Site West Allis Wisconsin
United States GSK Investigational Site West Hollywood California
United States GSK Investigational Site West Palm Beach Florida
United States GSK Investigational Site Wethersfield Connecticut
United States GSK Investigational Site Wheaton Illinois
United States GSK Investigational Site Wichita Kansas
United States GSK Investigational Site Wichita Kansas
United States GSK Investigational Site Wichita Kansas
United States GSK Investigational Site Wichita Kansas
United States GSK Investigational Site Williston Vermont
United States GSK Investigational Site Wilmington North Carolina
United States GSK Investigational Site Wilmington Delaware
United States GSK Investigational Site Wilton Manors Florida
United States GSK Investigational Site Winter Park Florida
United States GSK Investigational Site Winter Park Florida
United States GSK Investigational Site Youngstown Ohio
United States GSK Investigational Site Zephyrhills Florida

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary endpoint will be the rate of rash during 12 weeks. 12 Weeks No
Secondary Change from baseline in Week 5 and Week 12 Clinical Global Impression-Bipolar version (CGI-BP) Severityand Improvement scores. 12 Weeks No
See also
  Status Clinical Trial Phase
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT02855762 - Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder N/A
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT02513654 - Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects Phase 1
Recruiting NCT06313918 - Exercise Therapy in Mental Disorders-study N/A
Completed NCT02304432 - Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Early Phase 1
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT02212041 - Electronic Cigarettes in Smokers With Mental Illness N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Active, not recruiting NCT03641300 - Efficacy of Convulsive Therapies for Bipolar Depression N/A
Not yet recruiting NCT04432116 - Time and Virtual Reality in Schizophrenia and Bipolar Disorder N/A
Terminated NCT02909504 - Gao NARASD Lithium Study Phase 4
Terminated NCT02893371 - Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Completed NCT02970721 - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2